Is CMV DNAemia an early marker of CMV colitis in patients with active ulcerative colitis?

被引:0
|
作者
Melotti, Laura [1 ,2 ]
Rinaldi, Matteo [1 ,3 ]
Salice, Marco [2 ]
Dussias, Nikolas K. [1 ,2 ]
Vanigli, Nicholas [1 ,2 ]
Calabrese, Carlo [1 ,2 ]
Scaioli, Eleonora [2 ]
Gabrielli, Liliana [1 ,4 ]
Lazzarotto, Tiziana [1 ,4 ]
Rosini, Francesca [5 ]
Viale, Pierluigi [1 ,3 ]
Gionchetti, Paolo [1 ,2 ]
Giannella, Maddalena [1 ,3 ]
Rizzello, Fernando [1 ,2 ]
机构
[1] Alma Mater Studiorum Univ Bologna, Dept Med & Surg Sci, Bologna, Italy
[2] IRCCS Azienda Osped Univ Policlin St Orsola Malpig, Dept Med & Surg Sci, IBD Unit, Bologna, Italy
[3] IRCCS Azienda Osped Univ Bologna, Dept Integrated Risk Management, Infect Dis Unit, Bologna, Italy
[4] IRCCS Azienda Osped Univ Bologna, Microbiol Unit, Bologna, Italy
[5] IRCCS Azienda Osped Univ Bologna, Pathol Unit, Bologna, Italy
来源
MICROBIOLOGY SPECTRUM | 2024年 / 12卷 / 11期
关键词
CMV colitis; inflammatory bowel diseases; colectomy; INFLAMMATORY-BOWEL-DISEASE; CYTOMEGALOVIRUS-INFECTION; REACTIVATION; PREVALENCE; DIAGNOSIS; MODERATE; RISK;
D O I
10.1128/spectrum.01159-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Cytomegalovirus (CMV) colitis is a serious concern worsening the prognosis of patients with ulcerative colitis (UC). We aimed to assess risk factors and prognostic impact of CMV colitis in patients with moderate-to-severe UC flare. We conducted a retrospective, observational, single-center study. Consecutive adult patients hospitalized for moderate-to-severe UC from January 2020 to June 2023 were included. The primary endpoint was a diagnosis of CMV-colitis according to immunohistochemistry on tissue biopsies. The secondary endpoint was the need for colectomy within 30 days. Overall, 135 patients were included. CMV colitis was diagnosed in n = 37 (27.4%): n = 19 (51.4%) endoscopically, the remaining on surgical specimens. Of them, n = 23 (62.2%) had positive CMV-DNAemia with a median value of 1,008 cp/mL (interquartile range 318-2,980). Differences between the two groups (CMV colitis vs non-CMV) included age (60 vs 41 years, P = 0.004), Charlson Comorbidity Index (1 vs 0, P = 0.003), steroid refractoriness (86.5% vs 62.2%, P = 0.007), and positive CMV-DNAemia (62.2% vs 10.1%, P < 0.001). At multivariable analysis, steroid-refractory disease, Charlson Comorbidity Index, and CMV-DNAemia were associated with CMV colitis. Overall, n = 54 (39.7%) patients underwent colectomy, and this was significantly more common in patients with CMV colitis vs non-CMV group (54.1% vs 34.4%, P = 0.049). Kaplan-Meier showed that antiviral therapy seems to have a relevant impact on colectomy (P < 0.001). CMV-DNA blood detection is independently associated with CMV-positive refractory UC. Since CMV colitis may increase the risk of colectomy and antiviral treatment seems to reduce such risk, prospective studies are needed to confirm the role of CMV-DNA blood detection to early diagnose CMV colitis. IMPORTANCE Cytomegalovirus (CMV) colonic reactivation worsens the prognosis of patients with active ulcerative colitis. Blood CMV-DNA reactivation is strongly associated with CMV colitis. Prompt diagnosis and treatment of CMV colitis can avoid surgery in most cases.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis
    Yang, Hong
    Zhou, Weixun
    Lv, Hong
    Wu, Dongsheng
    Feng, Yunlu
    Shu, Huijun
    Jin, Meng
    Hu, Lingling
    Wang, Qiang
    Wu, Dong
    Chen, Jie
    Qian, Jiaming
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (05) : 814 - 821
  • [2] Always a Suspect: CMV in Ulcerative Colitis
    Kommareddy, Shirisha
    Chun, Carlene L.
    Rogers, William
    Triadafilopoulos, George
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (07) : 1838 - 1840
  • [3] The role of CMV in steroid-resistant ulcerative colitis: A systematic review
    Ayre, Karyn
    Warren, Bryan F.
    Jeffery, Katie
    Travis, Simon P. L.
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (03) : 141 - 148
  • [4] Seroprevalence of CMV infection in patients with active ulcerative colitis and underlying factors of pathogenicity
    Farahnaz Joukar
    Mohammad Almasi
    Narges Eslami
    Niloofar Faraji
    Kurosh Askari
    Ghazale Ghorbani
    Navid Yusefi
    Fariborz Mansour-Ghanaei
    BMC Infectious Diseases, 25 (1)
  • [5] Acute CMV-colitis in a patient with a history of ulcerative colitis
    Streetz, KL
    Buhr, T
    Wedemeyer, H
    Bleck, J
    Schedel, I
    Manns, MP
    Göke, MN
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2003, 38 (01) : 119 - 122
  • [6] Endoscopic Aspect of a Severe CMV Colitis induced by Azathioprine in a Patient with Ulcerative Colitis
    Preda, Carmen M.
    Sandra, Irina
    Becheanu, Gabriel
    Dumbrava, Mona
    Manuc, Mircea
    Diculescu, Mircea
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2016, 25 (04) : 429 - 429
  • [7] Acute Fulminant-Onset Synchronized CMV-Ulcerative Colitis
    Binicier, Omer Burcak
    Sari, Sevil Ozer
    ARCHIVES OF IRANIAN MEDICINE, 2019, 22 (02) : 99 - 101
  • [8] CMV in Moderately Active Colitis: Much Ado About Nothing?
    Moss, Alan C.
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (04) : 880 - 882
  • [9] Diagnostic Utility of Cytomegalovirus (CMV) DNA Quantitation in Ulcerative Colitis
    Esen, Sema
    Saglik, Imran
    Dolar, Enver
    Cesur, Selcan
    Ugras, Nesrin
    Agca, Harun
    Merdan, Osman
    Ener, Beyza
    VIRUSES-BASEL, 2024, 16 (05):
  • [10] CMV in the gut: a critical review of CMV detection in the immunocompetent host with colitis
    Goodman, A. L.
    Murray, C. D.
    Watkins, J.
    Griffiths, P. D.
    Webster, D. P.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2015, 34 (01) : 13 - 18